KYMR EPS Estimates
Kymera Therapeutics, Inc.
$138.62
+$6.89(+5.23%)
57
Overall
50
Value
66
Tech
55
Quality
Market Cap
$11.83B
Volume
686.78K
52W Range
$58.87 - $138.00
Target Price
$143.25
KYMR EPS estimates: the consensus estimate for Kymera Therapeutics, Inc.'s current fiscal year is -$3.88 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
KYMR EPS Estimates
- EPS estimate, current quarter
- $-1.29
- EPS estimate, next quarter
- $-1.34
- EPS estimate, current year
- $-3.88
- EPS estimate, next year
- $-5.31
- EPS growth, 3-year
- -8.74%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.69 |
| 2024 | $-2.98 |
| 2023 | $-2.52 |
| 2022 | $-2.87 |
| 2021 | $-2.09 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYMR | $138.62 | +5.2% | 686.78K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kymera Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW